Magdalena Hurkacz

509 total citations
37 papers, 350 citations indexed

About

Magdalena Hurkacz is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Magdalena Hurkacz has authored 37 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 9 papers in Cardiology and Cardiovascular Medicine and 8 papers in Epidemiology. Recurrent topics in Magdalena Hurkacz's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Heart Failure Treatment and Management (5 papers) and Pregnancy and Medication Impact (5 papers). Magdalena Hurkacz is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Heart Failure Treatment and Management (5 papers) and Pregnancy and Medication Impact (5 papers). Magdalena Hurkacz collaborates with scholars based in Poland, Belgium and United States. Magdalena Hurkacz's co-authors include Anna Wiela−Hojeńska, Wiesława Duszyńska, Andrzej Kübler, Beata Kowalska−Krochmal, Fabio Silvio Taccone, Łukasz Dobrek, Jan Biegus, Robert Zymliński, Piotr Ponikowski and M Switała and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and Critical Care.

In The Last Decade

Magdalena Hurkacz

36 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magdalena Hurkacz Poland 12 113 71 58 47 44 37 350
Max Taubert Germany 13 207 1.8× 93 1.3× 61 1.1× 22 0.5× 42 1.0× 42 478
Yoann Zerbib France 10 83 0.7× 105 1.5× 27 0.5× 74 1.6× 26 0.6× 32 313
F. Fauvelle France 11 89 0.8× 61 0.9× 20 0.3× 93 2.0× 33 0.8× 38 369
Jacob Sevastos Australia 6 38 0.3× 31 0.4× 47 0.8× 36 0.8× 29 0.7× 12 308
László Asztalos Hungary 15 61 0.5× 59 0.8× 110 1.9× 81 1.7× 37 0.8× 60 622
Toshiteru Ishitani Japan 9 57 0.5× 102 1.4× 104 1.8× 48 1.0× 87 2.0× 12 392
Cyril Leven France 11 89 0.8× 39 0.5× 31 0.5× 33 0.7× 16 0.4× 26 296
Diogo Diniz Gomes Bugano Brazil 14 68 0.6× 80 1.1× 60 1.0× 168 3.6× 69 1.6× 27 557
Houssem Hmouda Tunisia 10 52 0.5× 70 1.0× 74 1.3× 126 2.7× 95 2.2× 20 593
Agneta K. Hurst United States 8 116 1.0× 56 0.8× 124 2.1× 43 0.9× 32 0.7× 13 385

Countries citing papers authored by Magdalena Hurkacz

Since Specialization
Citations

This map shows the geographic impact of Magdalena Hurkacz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Hurkacz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Hurkacz more than expected).

Fields of papers citing papers by Magdalena Hurkacz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdalena Hurkacz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Hurkacz. The network helps show where Magdalena Hurkacz may publish in the future.

Co-authorship network of co-authors of Magdalena Hurkacz

This figure shows the co-authorship network connecting the top 25 collaborators of Magdalena Hurkacz. A scholar is included among the top collaborators of Magdalena Hurkacz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdalena Hurkacz. Magdalena Hurkacz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fudim, Marat, et al.. (2023). Relationship of Vascular Endothelial Growth Factor C, a Lymphangiogenesis Modulator, With Edema Formation, Congestion and Outcomes in Acute Heart Failure. Journal of Cardiac Failure. 29(12). 1629–1638. 14 indexed citations
6.
Hurkacz, Magdalena, et al.. (2022). Safety of drugs used during pregnancy and lactation as a result of changes in their pharmacokinetics. SHILAP Revista de lepidopterología. 78(10). 589–596. 1 indexed citations
7.
Biegus, Jan, et al.. (2022). Cardiorenal syndrome: Decongestion in heart failure across wide spectrum of kidney pathophysiology. Advances in Clinical and Experimental Medicine. 31(4). 445–455. 6 indexed citations
8.
Nawrocka‐Millward, Sylwia, Jan Biegus, Magdalena Hurkacz, et al.. (2021). Differences in the Biomarker Profile of De Novo Acute Heart Failure versus Decompensation of Chronic Heart Failure. Biomolecules. 11(11). 1701–1701. 12 indexed citations
9.
Hurkacz, Magdalena, et al.. (2021). Role of resistin in cardiovascular diseases: Implications for prevention and treatment. Advances in Clinical and Experimental Medicine. 30(8). 865–874. 11 indexed citations
10.
Wojciechowski, Robert, et al.. (2018). CYP2D6 basic genotyping as a potential tool to improve antiemetic efficacy of ondansetron in prophylaxis of postoperative nausea and vomiting. Advances in Clinical and Experimental Medicine. 27(11). 1499–1503. 11 indexed citations
12.
Duszyńska, Wiesława, Fabio Silvio Taccone, Magdalena Hurkacz, et al.. (2013). Therapeutic drug monitoring of amikacin in septic patients. Critical Care. 17(4). R165–R165. 61 indexed citations
13.
Duszyńska, Wiesława, Fabio Silvio Taccone, M Switała, et al.. (2011). Continuous infusion of piperacillin/tazobactam in ventilator-associated pneumonia: a pilot study on efficacy and costs. International Journal of Antimicrobial Agents. 39(2). 153–158. 27 indexed citations
14.
Bieniek, Andrzej, et al.. (2009). Optimization of lidocaine application in tumescent local anesthesia. Pharmacological Reports. 61(4). 641–653. 13 indexed citations
15.
Danielewicz, Hanna, Magdalena Hurkacz, Andrzej Boznański, & Anna Wiela−Hojeńska. (2007). Polymorphism in the Promoter and Coding Region of the IL−4 Receptor Alpha−Chain Gene in Atopic Children. Advances in Clinical and Experimental Medicine. 16(6). 735–741. 1 indexed citations
16.
Medrala, W, et al.. (2003). [Significance of CYP2D6 oxidation genotype as a risk factor in development of allergic diseases].. PubMed. 109(2). 137–42. 3 indexed citations
17.
Kos, Mojca Kerec, et al.. (2003). The influence of locally implanted high doses of gentamicin on hearing and renal function of newborns treated for acute hematogenous osteomyelitis. International Journal of Clinical Pharmacology and Therapeutics. 41(7). 281–286. 11 indexed citations
18.
Wiland, Piotr, et al.. (2003). [Renal tubular dysfunction in patients with rheumatoid arthritis starting with low dose of methotrexate].. PubMed. 110(2). 855–62. 5 indexed citations
19.
Niewiński, Piotr, et al.. (2002). CYP2D6 extensive, intermediate, and poor phenotypes and genotypes in a Polish population. European Journal of Clinical Pharmacology. 58(8). 533–535. 24 indexed citations
20.
Wiela−Hojeńska, Anna & Magdalena Hurkacz. (1998). [The significance of beta 2-microglobulin in diagnosis and therapy].. PubMed. 52(5). 507–14. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026